{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:00:10Z","timestamp":1787792410658,"version":"build-2784847793"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.intimp.2022.109337","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T07:37:49Z","timestamp":1666251469000},"page":"109337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"PA","title":["Systemic administration of dorsomorphin relieves inflammatory nociception in the mouse formalin test"],"prefix":"10.1016","volume":"113","author":[{"given":"Yin","family":"Xinqiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yuanyuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Zhipeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Yumeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Chenxi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duan","family":"Shiyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Mingpeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Yanlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Sihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2022.109337_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113862","article-title":"Peripheral nitric oxide signaling directly blocks inflammatory pain","volume":"176","author":"Gomes","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2022.109337_b0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-1-4939-7598-3_12","article-title":"Compound C\/Dorsomorphin: Its Use and Misuse as an AMPK Inhibitor","volume":"1732","author":"Dasgupta","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.intimp.2022.109337_b0015","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1194\/jlr.M900119-JLR200","article-title":"AMPK inhibitor Compound C stimulates ceramide production and promotes Bax redistribution and apoptosis in MCF7 breast carcinoma cells","volume":"50","author":"Jin","year":"2009","journal-title":"J. Lipid Res."},{"issue":"6","key":"10.1016\/j.intimp.2022.109337_b0020","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3390\/cancers11060823","article-title":"Compound C Inhibits B16\u2013F1 Tumor Growth in a Syngeneic Mouse Model Via the Blockage of Cell Cycle Progression and Angiogenesis","volume":"11","author":"Lee","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2022.109337_b0025","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1248\/bpb.b15-00938","article-title":"Compound C Increases Sestrin2 Expression via Mitochondria-Dependent ROS Production.pdf","volume":"39","author":"Kyuhwa Seo","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.intimp.2022.109337_b0030","doi-asserted-by":"crossref","first-page":"e45845","DOI":"10.1371\/journal.pone.0045845","article-title":"Compound C prevents the unfolded protein response during glucose deprivation through a mechanism independent of AMPK and BMP signaling","volume":"7","author":"Saito","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2022.109337_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.612778","article-title":"Compound C, a Broad Kinase Inhibitor Alters Metabolic Fingerprinting of Extra Cellular Matrix Detached Cancer Cells","volume":"11","author":"Shait Mohammed","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2022.109337_b0040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.atherosclerosis.2011.06.043","article-title":"Compound C independent of AMPK inhibits ICAM-1 and VCAM-1 expression in inflammatory stimulants-activated endothelial cells in vitro and in vivo","volume":"219","author":"Kim","year":"2011","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.intimp.2022.109337_b0045","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bbrc.2015.12.015","article-title":"Compound C inhibits macrophage chemotaxis through an AMPK-independent mechanism","volume":"469","author":"Lee","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2022.109337_b0050","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00210-019-01712-4","article-title":"Compound C attenuates NLRP3 inflammasome despite AMPK knockdown in LPS plus palmitate-induced THP-1 cells","volume":"393","author":"Liu","year":"2020","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.intimp.2022.109337_b0055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fphar.2020.00088","article-title":"Compound C Reducing Interferon Expression by Inhibiting cGAMP Accumulation","volume":"11","author":"Lai","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2022.109337_b0060","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1090-3801(98)90033-7","article-title":"Scoring the mouse formalin test: validation study","volume":"2","author":"Sufka","year":"1998","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.intimp.2022.109337_b0065","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3389\/fphys.2020.01016","article-title":"The NLRP3 Inflammasome: Role and Therapeutic Potential in Pain Treatment","volume":"11","author":"Starobova","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.intimp.2022.109337_b0070","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.bjp.0701148","article-title":"Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha","volume":"121","author":"Woolf","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2022.109337_b0075","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1476-5381.1992.tb14503.x","article-title":"The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia","volume":"107","author":"Cunha","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2022.109337_b0080","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0028-3908(94)90171-6","article-title":"Interleukin-1 beta induced-desArg9bradykinin-mediated thermal hyperalgesia in the rat","volume":"33","author":"Perkins","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2022.109337_b0085","first-page":"145","article-title":"Cytokines and peripheral nerve disorders","volume":"8","author":"Creange","year":"1997","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.intimp.2022.109337_b0090","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1097\/00001756-199611250-00018","article-title":"Endoneurial injection of TNF-alpha produces neuropathic pain behaviors","volume":"7","author":"Wagner","year":"1996","journal-title":"NeuroReport"},{"key":"10.1016\/j.intimp.2022.109337_b0095","unstructured":"S.D.J. Sweitzer, D. Martin, Intrathecal interleukin-1 receptor antagonist and tumor necrosis factor binding protein exhibit an antiallodynic effect in a rat model of neuropathic pain, Soc. Neurosci. Abstr. (1999) 25579.4."},{"key":"10.1016\/j.intimp.2022.109337_b0100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0165-5728(01)00324-1","article-title":"Expression of interleukin-1 beta in rat dorsal root ganglia","volume":"118","author":"Copray","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2022.109337_b0105","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1002\/eji.1830221131","article-title":"Expression of interleukin (IL)-1 beta, IL-6 and their respective receptors in the normal rat brain and after injury","volume":"22","author":"Yan","year":"1992","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2022.109337_b0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0006-8993(94)91566-0","article-title":"Characterization of cytokine-induced hyperalgesia","volume":"654","author":"Watkins","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.intimp.2022.109337_b0115","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0306-4522(95)00106-S","article-title":"Interleukin-1 beta induces long-term increase of axonally transported opiate receptors and substance P","volume":"68","author":"Jeanjean","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2022.109337_b0120","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/BF01965025","article-title":"Interleukin-1 enhances pain reflexes. Mediation through increased prostaglandin E2 levels","volume":"25","author":"Schweizer","year":"1988","journal-title":"Agents Actions."},{"key":"10.1016\/j.intimp.2022.109337_b0125","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-8993(93)91446-Y","article-title":"Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin","volume":"623","author":"Maier","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.intimp.2022.109337_b0130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0306-4522(00)00574-1","article-title":"Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain","volume":"103","author":"Sweitzer","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2022.109337_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.783725","article-title":"Interferons in Pain and Infections: Emerging Roles in Neuro-Immune and Neuro-Glial Interactions","volume":"12","author":"Tan","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2022.109337_b0140","doi-asserted-by":"crossref","first-page":"418","DOI":"10.4062\/biomolther.2015.168","article-title":"Antinociceptive Effects of Prim-O-Glucosylcimifugin in Inflammatory Nociception via Reducing Spinal COX-2","volume":"24","author":"Wu","year":"2016","journal-title":"Biomol. Therapeut."},{"key":"10.1016\/j.intimp.2022.109337_b0145","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12974-020-1703-1","article-title":"Molecular mechanisms underlying the actions of arachidonic acid-derived prostaglandins on peripheral nociception","volume":"17","author":"Jang","year":"2020","journal-title":"J. Neuroinflam."},{"key":"10.1016\/j.intimp.2022.109337_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117885","article-title":"p38 mitogen-activated protein kinase and pain","volume":"256","author":"Mai","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2022.109337_b0155","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cellimm.2011.06.021","article-title":"NF-\u03baB cellular and molecular regulatory mechanisms and pathways: therapeutic pattern or pseudoregulation?","volume":"271","author":"Haddad","year":"2011","journal-title":"Cell Immunol."},{"key":"10.1016\/j.intimp.2022.109337_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0361-9230(97)00277-3","article-title":"Using c-fos as a neural marker of pain","volume":"45","author":"Ja","year":"1998","journal-title":"Brain Res Bull."},{"key":"10.1016\/j.intimp.2022.109337_b0165","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ng859","article-title":"c-fos regulates neuronal excitability and survival","volume":"30","author":"Zhang","year":"2002","journal-title":"Nat Genet."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922008219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922008219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:57:58Z","timestamp":1761587878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922008219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":33,"alternative-id":["S1567576922008219"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109337","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic administration of dorsomorphin relieves inflammatory nociception in the mouse formalin test","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109337"}}